Sumitomo Mitsui Trust Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$689K Buy
12,200
+500
+4% +$29.2K ﹤0.01% 895
2025
Q4
$695K Sell
11,700
-440,280
-97% -$24M ﹤0.01% 896
2025
Q3
$24.5M Sell
451,980
-40,124
-8% -$2.29M 0.01% 620
2025
Q2
$27.1M Buy
492,104
+24,859
+5% +$1.46M 0.02% 599
2025
Q1
$33M Sell
467,245
-2,798
-0.6% -$188K 0.02% 553
2024
Q4
$30.9M Buy
470,043
+13,946
+3% +$934K 0.02% 578
2024
Q3
$32.1M Buy
456,097
+20,631
+5% +$1.72M 0.02% 570
2024
Q2
$35.9M Sell
435,466
-42,034
-9% -$3.5M 0.03% 512
2024
Q1
$41.7M Sell
477,500
-4,096
-0.9% -$367K 0.03% 547
2023
Q4
$46.4M Sell
481,596
-5,805
-1% -$514K 0.03% 495
2023
Q3
$43.1M Sell
487,401
-14,122
-3% -$1.26M 0.04% 495
2023
Q2
$43.5M Sell
501,523
-82,377
-14% -$7.75M 0.03% 515
2023
Q1
$56.8M Sell
583,900
-2,320
-0.4% -$241K 0.04% 455
2022
Q4
$60.7M Sell
586,220
-6,472
-1% -$608K 0.05% 434
2022
Q3
$50.2M Buy
592,692
+3,407
+0.6% +$303K 0.04% 482
2022
Q2
$48.8M Buy
589,285
+25,294
+4% +$2.01M 0.04% 520
2022
Q1
$43.5M Buy
563,991
+308
+0.1% +$25.8K 0.03% 577
2021
Q4
$49.8M Buy
563,683
+34,324
+6% +$2.83M 0.03% 535
2021
Q3
$40.9M Sell
529,359
-21,497
-4% -$1.7M 0.03% 590
2021
Q2
$46M Sell
550,856
-35,489
-6% -$2.81M 0.03% 574
2021
Q1
$44.3M Sell
586,345
-30,584
-5% -$2.5M 0.03% 577
2020
Q4
$54.1M Sell
616,929
-343,698
-36% -$27.2M 0.04% 506
2020
Q3
$73.1M Buy
960,627
+242,035
+34% +$24.5M 0.05% 384
2020
Q2
$88.6M Buy
718,592
+4,257
+0.6% +$423K 0.06% 332
2020
Q1
$60.4M Buy
714,335
+31,414
+5% +$2.71M 0.05% 386
2019
Q4
$57.7M Buy
682,921
+10,398
+2% +$785K 0.05% 422
2019
Q3
$45.3M Sell
672,523
-2,532
-0.4% -$195K 0.04% 473
2019
Q2
$57.8M Sell
675,055
-69,897
-9% -$5.98M 0.05% 383
2019
Q1
$66.2M Buy
744,952
+67,321
+10% +$6.24M 0.06% 335
2018
Q4
$56.6M Buy
677,631
+109,630
+19% +$10.4M 0.06% 327
2018
Q3
$55.1M Buy
568,001
+12,603
+2% +$1.26M 0.06% 345
2018
Q2
$52.3M Buy
555,398
+61,915
+13% +$5.42M 0.06% 347
2018
Q1
$40M Buy
493,483
+3,719
+0.8% +$319K 0.05% 401
2017
Q4
$43.7M Buy
489,764
+13,598
+3% +$1.18M 0.06% 360
2017
Q3
$44.3M Sell
476,166
-69,208
-13% -$6.12M 0.06% 329
2017
Q2
$49.5M Buy
545,374
+45,664
+9% +$4.15M 0.07% 302
2017
Q1
$43.9M Buy
499,710
+27,335
+6% +$2.43M 0.07% 316
2016
Q4
$39.1M Buy
472,375
+27,178
+6% +$2.34M 0.06% 336
2016
Q3
$41.2M Buy
445,197
+2,448
+0.6% +$231K 0.07% 329
2016
Q2
$34.4M Sell
442,749
-1,979
-0.4% -$168K 0.06% 360
2016
Q1
$36.7M Sell
444,728
-2,634
-0.6% -$214K 0.06% 344
2015
Q4
$47.3M Sell
447,362
-2,948
-0.7% -$308K 0.08% 269
2015
Q3
$47.4M Buy
450,310
+20,795
+5% +$2.78M 0.09% 261
2015
Q2
$58.7M Buy
429,515
+12,307
+3% +$1.53M 0.11% 235
2015
Q1
$52M Buy
417,208
+79,122
+23% +$8.38M 0.09% 261
2014
Q4
$30.5M Sell
338,086
-8,834
-3% -$735K 0.06% 373
2014
Q3
$25M Sell
346,920
-1,333
-0.4% -$87.6K 0.05% 424
2014
Q2
$21.7M Sell
348,253
-38,733
-10% -$2.34M 0.04% 464
2014
Q1
$26.4M Buy
386,986
+28,382
+8% +$2.09M 0.06% 402
2013
Q4
$24.9M Sell
358,604
-8,976
-2% -$610K 0.05% 418
2013
Q3
$26.5M Buy
367,580
+45,293
+14% +$3.01M 0.06% 383
2013
Q2
$18M Buy
+322,287
New +$20.1M 0.04% 485

Other funds holding BMRN